Analysts Set STERIS plc (NYSE:STE) Target Price at $253.00

Shares of STERIS plc (NYSE:STEGet Free Report) have received an average rating of “Moderate Buy” from the six research firms that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $253.00.

STE has been the subject of a number of analyst reports. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research note on Wednesday, August 7th. StockNews.com lowered STERIS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 29th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research report on Thursday, August 8th. Stephens reaffirmed an “overweight” rating and set a $260.00 target price on shares of STERIS in a research note on Wednesday, August 7th. Finally, KeyCorp increased their price target on shares of STERIS from $255.00 to $265.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 3rd.

Get Our Latest Report on STERIS

Insider Activity at STERIS

In related news, CFO Michael J. Tokich sold 23,332 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $247.00, for a total transaction of $5,763,004.00. Following the transaction, the chief financial officer now owns 42,930 shares of the company’s stock, valued at approximately $10,603,710. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.14% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On STERIS

Several institutional investors have recently bought and sold shares of STE. Ashton Thomas Securities LLC acquired a new position in shares of STERIS during the 3rd quarter valued at about $25,000. J.Safra Asset Management Corp lifted its holdings in STERIS by 77.9% in the 1st quarter. J.Safra Asset Management Corp now owns 121 shares of the medical equipment provider’s stock worth $27,000 after purchasing an additional 53 shares during the last quarter. Central Pacific Bank Trust Division bought a new stake in STERIS during the third quarter worth approximately $28,000. Quent Capital LLC grew its holdings in STERIS by 112.7% during the first quarter. Quent Capital LLC now owns 134 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 71 shares during the last quarter. Finally, Headlands Technologies LLC bought a new position in shares of STERIS in the first quarter valued at approximately $36,000. 94.69% of the stock is currently owned by institutional investors.

STERIS Trading Up 0.0 %

STERIS stock opened at $227.52 on Monday. The firm has a market cap of $22.44 billion, a price-to-earnings ratio of 56.46 and a beta of 0.85. STERIS has a 1 year low of $195.47 and a 1 year high of $248.24. The firm’s 50 day moving average price is $233.17 and its two-hundred day moving average price is $227.60. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.49 and a current ratio of 2.33.

STERIS (NYSE:STEGet Free Report) last issued its earnings results on Tuesday, August 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.98 by $0.16. The business had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.27 billion. STERIS had a return on equity of 13.85% and a net margin of 7.36%. The company’s quarterly revenue was down .4% on a year-over-year basis. During the same period in the previous year, the firm posted $2.00 EPS. On average, research analysts predict that STERIS will post 9.02 EPS for the current fiscal year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Tuesday, November 19th will be paid a dividend of $0.57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date of this dividend is Tuesday, November 19th. STERIS’s dividend payout ratio (DPR) is presently 56.58%.

About STERIS

(Get Free Report

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Further Reading

Analyst Recommendations for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.